DCSIMG

Cancer Research UK to have branch at Babraham Research Park

A national cancer charity has agreed to lease a building at the Babraham Research Park.

A national cancer charity has agreed to lease a building at the Babraham Research Park.

Cancer Research Technology Limited (CRT), the cancer-focused technology development and commercialisation arm of Cancer Research UK, the world’s largest cancer charity, has leased the new chemistry building currently under construction in Babraham.

The building is due for completion in April 2013 and will house part of CRT’s Discovery Laboratories, its early-stage drug discovery operation.

The Babraham campus has established itself as a hub of bioscience innovation and is home to 36 innovative biomedical companies.

This new research facility has been funded through the £44 million capital development project awarded to the Biotechnology and Biological Sciences Research Council (BBSRC), which was announced the Chancellor George Osbourne in 2011.

The building offers around 16,000 sq ft of lettable space, which will include 24 fume hoods, open plan bench space, offices and meeting rooms.

CRT has taken a lease on half of the building, which will accommodate up to 30 of its researchers working in the area of cancer therapeutics (both bioscience and chemistry).

This is the second building financed through this capital project funding, the first being Babraham’s most recent bioincubator building Moneta, which opened in April 2012.

To date there are five bioincubator buildings at the campus, underscoring Babraham’s continuing commitment to nurturing early-stage enterprises and supporting biomedical innovation in the region.

The Babraham Research Campus is strategically supported by the BBSRC.

For all the latest news see Thursday’s (December 13) Echo.

 

Comments

 
 

Back to the top of the page